Replimune Group (REPL) Earnings Date, Estimates & Call Transcripts $9.65 +0.25 (+2.66%) Closing price 04:00 PM EasternExtended Trading$9.72 +0.07 (+0.78%) As of 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Replimune Group Earnings Summary Replimune Group posted Q4 2025 earnings on May 22, 2025, reporting an EPS of -$0.82, which missed analysts' consensus estimates of -$0.75 by $0.07. With a trailing EPS of -$3.07, Replimune Group's earnings are expected to grow next year, from ($2.97) to ($2.55) per share. Upcoming Q1 Earnings DateAug. 14Before Market OpensEstimatedConsensus EPS (May. 22) -$0.75 Actual EPS (May. 22) -$0.82 Missed By -$0.07 Q4 2025 Earnings ResourcesQ4 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Report Annual Report (10-K)SEC FilingREPL Upcoming EarningsReplimune Group's next earnings date is estimated for Thursday, August 14, 2025, based on past reporting schedules. Powered by Get Replimune Group Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Replimune Group and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataREPL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Replimune Group Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.85-$0.70-$0.77Q2 20254-$0.87-$0.70-$0.79Q3 20254-$0.88-$0.63-$0.74Q4 20254-$0.90-$0.69-$0.79 FY 2025 15 -$3.50 -$2.72 -$3.08 Q1 20263-$0.92-$0.70-$0.82Q2 20263-$0.96-$0.63-$0.78Q3 20264-$0.93-$0.52-$0.69Q4 20264-$0.85-$0.52-$0.65 Replimune Group Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/14/2025(Estimated)--------5/22/2025Q4 2025-$0.75-$0.82 -$0.07-$0.82--2/12/2025Q3 2025-$0.70-$0.79 -$0.09-$0.79--11/12/2024--$0.75-$0.68+$0.07-$0.68--8/8/2024--$0.88-$0.78+$0.10-$0.78--5/16/2024Q4 2024-$0.86-$0.82+$0.04-$0.82--2/8/2024Q3 2024-$0.89-$0.77+$0.12-$0.77--11/7/2023Q2 2024-$0.80-$0.90 -$0.10-$0.90--8/3/2023Q1 2024-$0.80-$0.75+$0.05-$0.75-- Replimune Group Earnings - Frequently Asked Questions When is Replimune Group's earnings date? Replimune Group has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 14th, 2025 based off last year's report dates. Learn more on REPL's earnings history. Did Replimune Group beat their earnings estimates last quarter? In the previous quarter, Replimune Group (NASDAQ:REPL) missed the analysts' consensus estimate of ($0.75) by $0.07 with a reported earnings per share (EPS) of ($0.82). Learn more on analysts' earnings estimate vs. REPL's actual earnings. How can I listen to Replimune Group's earnings conference call? The conference call for Replimune Group's latest earnings report can be listened to online. Listen to Conference Call How can I read Replimune Group's conference call transcript? The conference call transcript for Replimune Group's latest earnings report can be read online. Read Transcript How can I view Replimune Group's earnings report? Replimune Group's earnings report can be found in their filing with the SEC. View SEC filing How much profit does Replimune Group generate each year? Replimune Group (NASDAQ:REPL) has a recorded net income of -$247.30 million. REPL has generated -$3.07 earnings per share over the last four quarters. What is Replimune Group's EPS forecast for next year? Replimune Group's earnings are expected to grow from ($2.97) per share to ($2.55) per share in the next year. More Earnings Resources from MarketBeat Related Companies Kymera Therapeutics Earnings Date Alvotech Earnings Date Immunovant Earnings Date Crinetics Pharmaceuticals Earnings Date Catalyst Pharmaceuticals Earnings Date Amneal Pharmaceuticals Earnings Date Mirum Pharmaceuticals Earnings Date Organon & Co. Earnings Date Bausch Health Cos Earnings Date Xenon Pharmaceuticals Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs This page (NASDAQ:REPL) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Replimune Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Replimune Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free REPL Stock Alerts